NEW STUDY SHOWS BOND-III UP TO 40% FASTER THAN BENCHMARK ULTRA.

 

WINNING THE CASE RACE


In a recent study, the Leica Biosystems BOND-III was found to complete cases up to 100 minutes faster than the Roche Tissue Diagnostics BenchMark ULTRA. The study examines the panel turnaround time to assess the impact that fully automated IHC and ISH slide stainers such as the BOND-III and BenchMark ULTRA can have delivering the full panel of slides to a pathologist. The scope of the testing was across 10 frequently run hematopathology IHC panels. 

STUDY FINDINGS


Source: A comparative study of turnaround times for common hematopathology panels on the Leica Biosystems BOND‑III and the Roche Tissue Diagnostics BenchMark ULTRA instruments, 2018. 

 

 
 

READ THE STUDY NOW

 

 

ABOUT US


Leica Biosystems (LeicaBiosystems.com) is a global leader in workflow solutions and automation, integrating each step in the workflow from biopsy to diagnosis. Our mission of "Advancing Cancer Diagnostics, Improving Lives" is at the heart of our corporate culture. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence.

FILL IN YOUR DETAILS TO DOWNLOAD THE STUDY

Our privacy promise:
your email will never be shared.